JP2006311860A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006311860A5 JP2006311860A5 JP2006119595A JP2006119595A JP2006311860A5 JP 2006311860 A5 JP2006311860 A5 JP 2006311860A5 JP 2006119595 A JP2006119595 A JP 2006119595A JP 2006119595 A JP2006119595 A JP 2006119595A JP 2006311860 A5 JP2006311860 A5 JP 2006311860A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- matrix metalloproteinase
- kda
- approximately
- urine sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 claims description 31
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 29
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims description 29
- 210000002700 urine Anatomy 0.000 claims description 22
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 206010006187 Breast cancer Diseases 0.000 claims description 10
- 208000026310 Breast neoplasm Diseases 0.000 claims description 10
- 238000003745 diagnosis Methods 0.000 claims description 10
- 210000002889 endothelial cell Anatomy 0.000 claims description 10
- 102000013382 Gelatinases Human genes 0.000 claims description 8
- 108010026132 Gelatinases Proteins 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 6
- 238000001962 electrophoresis Methods 0.000 claims description 6
- 206010005003 Bladder cancer Diseases 0.000 claims description 4
- 206010060862 Prostate cancer Diseases 0.000 claims description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 4
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 4
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 4
- 238000002965 ELISA Methods 0.000 claims description 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 206010038389 Renal cancer Diseases 0.000 claims description 2
- 208000016624 Retinal neoplasm Diseases 0.000 claims description 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 208000024558 digestive system cancer Diseases 0.000 claims description 2
- 201000010231 gastrointestinal system cancer Diseases 0.000 claims description 2
- 230000003054 hormonal effect Effects 0.000 claims description 2
- 230000000984 immunochemical effect Effects 0.000 claims description 2
- 201000010982 kidney cancer Diseases 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 239000013541 low molecular weight contaminant Substances 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 201000011682 nervous system cancer Diseases 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 238000003127 radioimmunoassay Methods 0.000 claims description 2
- 201000008933 retinal cancer Diseases 0.000 claims description 2
- 201000000849 skin cancer Diseases 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 229960003604 testosterone Drugs 0.000 claims description 2
- 108050008315 Matrix metalloproteinase-A Proteins 0.000 claims 1
- 208000006593 Urologic Neoplasms Diseases 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63937396A | 1996-04-26 | 1996-04-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09539033A Division JP2000510949A (ja) | 1996-04-26 | 1997-04-25 | 組織のリモデリングに関連した状態のための非観血的酵素スクリーン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006311860A JP2006311860A (ja) | 2006-11-16 |
| JP2006311860A5 true JP2006311860A5 (enExample) | 2007-06-28 |
Family
ID=24563830
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09539033A Pending JP2000510949A (ja) | 1996-04-26 | 1997-04-25 | 組織のリモデリングに関連した状態のための非観血的酵素スクリーン |
| JP2006119595A Ceased JP2006311860A (ja) | 1996-04-26 | 2006-04-24 | 組織のリモデリングに関連した状態のための非観血的酵素スクリーン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09539033A Pending JP2000510949A (ja) | 1996-04-26 | 1997-04-25 | 組織のリモデリングに関連した状態のための非観血的酵素スクリーン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6037138A (enExample) |
| EP (3) | EP2060917B9 (enExample) |
| JP (2) | JP2000510949A (enExample) |
| AU (1) | AU2681997A (enExample) |
| CA (1) | CA2252648C (enExample) |
| WO (1) | WO1997041441A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6811995B1 (en) * | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
| GB9905817D0 (en) * | 1999-03-12 | 1999-05-05 | Oxford Glycosciences Uk Ltd | Methods |
| CA2267481A1 (en) * | 1999-03-30 | 2000-09-30 | Gabriel Pulido-Cejudo | Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection |
| WO2000070340A2 (en) * | 1999-05-14 | 2000-11-23 | Karolinska Innovations Ab | Materials and methods relating to disease diagnosis |
| US7482135B2 (en) | 2000-05-17 | 2009-01-27 | Nederlandse Organisatie Voor Toegepast | Proteolytic enzymes in urine as diagnostic parameters in diseases involving matrix remodelling |
| EP1832876A3 (en) * | 2000-10-13 | 2008-04-23 | Children's Medical Center Corporation | Non-invasive enzyme screen for tissue remodelling-associated conditions |
| AU2002211697B2 (en) | 2000-10-13 | 2005-12-15 | Children's Medical Center Corporation | Non-invasive enzyme screen for tissue remodelling-associated conditions |
| US20040029200A1 (en) * | 2002-05-22 | 2004-02-12 | Thomas Weimbs | Method and kits for the detection of renal cell carcinoma in a biological fluid of a patient |
| EP1581103A4 (en) * | 2002-12-12 | 2007-01-31 | Manoa Medical Inc | PERKUTANE REMOVAL OF A KEEPER NODE USING CONTRAST IMAGE IDENTIFICATION |
| WO2006084109A2 (en) * | 2005-02-02 | 2006-08-10 | Pro Term, Inc. | Salivary protease assays for identifying increased risk of preterm delivery induced by premature rupture of fetal membranes |
| CA2642833A1 (en) * | 2006-02-17 | 2007-08-30 | Children's Medical Center Corporation | Free ngal as a biomarker for cancer |
| WO2008138522A1 (en) * | 2007-05-10 | 2008-11-20 | Roche Diagnostics Gmbh | Use of timp-1 as a marker for colorectal cancer |
| US10107782B2 (en) | 2008-01-25 | 2018-10-23 | ProteinSimple | Method to perform limited two dimensional separation of proteins and other biologicals |
| US9804079B2 (en) | 2012-04-19 | 2017-10-31 | ProteinSimple | Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates |
| US20150093757A1 (en) * | 2013-09-27 | 2015-04-02 | Protein Simple | Methods. apparatus and systems for detection of total protein using capillary electrophoresis |
| IN202021002695A (enExample) | 2020-01-21 | 2021-07-23 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5051361A (en) | 1988-10-19 | 1991-09-24 | Sigma Chemical Company | AZT immunoassays, derivatives, conjugates and antibodies |
| US5096815A (en) | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| US5340720A (en) * | 1989-11-29 | 1994-08-23 | University Of Kansas | Methods of diagnosing and monitoring rheumatic diseases |
| AU647459B2 (en) * | 1990-01-26 | 1994-03-24 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A method for quantitatively measuring collagenase |
| JP2503716B2 (ja) * | 1990-04-06 | 1996-06-05 | 日東紡績株式会社 | 酸性ホスファタ―ゼ活性測定法 |
| SE9002480D0 (sv) * | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
| US5233409A (en) | 1992-02-25 | 1993-08-03 | Schwab Karl W | Color analysis of organic constituents in sedimentary rocks for thermal maturity |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| EP0648205B1 (en) * | 1993-04-27 | 1999-07-14 | Celltech Therapeutics Limited | Peptidyl derivatives as metalloproteinase inhibitors |
| WO1995015374A1 (en) * | 1993-11-30 | 1995-06-08 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Novel metalloprotease and dna coding for the same |
| US5639656A (en) * | 1994-03-31 | 1997-06-17 | Medical College Of Hampton Road | Antibodies reactive with biological markers of benign prostate hyperplasia |
| US5654161A (en) * | 1995-05-12 | 1997-08-05 | Chiron Diagnostics Corporation | Method for diagnosing prostate cancer |
-
1997
- 1997-04-25 WO PCT/US1997/006909 patent/WO1997041441A1/en not_active Ceased
- 1997-04-25 EP EP09002819.2A patent/EP2060917B9/en not_active Expired - Lifetime
- 1997-04-25 EP EP03078366A patent/EP1418434A3/en not_active Withdrawn
- 1997-04-25 JP JP09539033A patent/JP2000510949A/ja active Pending
- 1997-04-25 CA CA002252648A patent/CA2252648C/en not_active Expired - Lifetime
- 1997-04-25 EP EP97918808A patent/EP0900381A1/en not_active Withdrawn
- 1997-04-25 AU AU26819/97A patent/AU2681997A/en not_active Abandoned
- 1997-04-25 US US08/843,095 patent/US6037138A/en not_active Expired - Lifetime
-
2006
- 2006-04-24 JP JP2006119595A patent/JP2006311860A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006311860A5 (enExample) | ||
| WO2010056337A3 (en) | Methods and systems of using exosomes for determining phenotypes | |
| WO2010057184A3 (en) | Methods for detection of acute kidney injury in humans | |
| JP2010516678A5 (enExample) | ||
| HK1199754A1 (en) | Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage | |
| WO2012174282A3 (en) | Biomarker compositions and methods | |
| WO2011047033A3 (en) | Biomarker for identification of melanoma tumor cells | |
| WO2012054638A3 (en) | Nmr systems and methods for the detection of analytes | |
| WO2012006589A3 (en) | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| WO2011028698A3 (en) | Mri and optical assays for proteases | |
| WO2009085234A3 (en) | Use of micro-rna as a biomarker of immunomodulatory drug activity | |
| MX366653B (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| WO2010025393A3 (en) | Protein biomarkers and methods for diagnosing kawasaki disease | |
| WO2008140774A3 (en) | Methods for diagnosing and treating prostate and lung cancer | |
| WO2006073682A3 (en) | Diagnostic test | |
| WO2011015602A3 (en) | Lung cancer biomarkers | |
| WO2017027391A3 (en) | Genetic abnormalities in plasma cell dyscrasias | |
| MX339340B (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| WO2007013575A3 (en) | Method for diagnosing and treating renal cell carcinoma | |
| WO2010084327A3 (en) | Methods | |
| WO2011052906A3 (en) | Use of eif3m for the diagnosis and treatment of cancer | |
| WO2010090834A3 (en) | Netrin-1 as a biomarker of injury and disease | |
| WO2007056523A3 (en) | Methods for diagnosing and monitoring the progression of cancer | |
| WO2005085292A3 (fr) | Procede de detection de la forme libre activable du psa et son utilisation pour le diagnostic des pathologies benignes de la prostate et de l'adenocarcinome de la prostate |